-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Gy4fZApcRnkqvINkqEfaY9caqGWOzHZQE57NRTQootxK9hkMRI0EXAZ8yqRHXmzw OCo+QM7X9cA4dxIQLUkDtQ== 0000905148-06-003639.txt : 20060508 0000905148-06-003639.hdr.sgml : 20060508 20060508165124 ACCESSION NUMBER: 0000905148-06-003639 CONFORMED SUBMISSION TYPE: SC 13G PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20060508 DATE AS OF CHANGE: 20060508 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: SEROLOGICALS CORP CENTRAL INDEX KEY: 0000767673 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 582152225 STATE OF INCORPORATION: DE FISCAL YEAR END: 1206 FILING VALUES: FORM TYPE: SC 13G SEC ACT: 1934 Act SEC FILE NUMBER: 005-46047 FILM NUMBER: 06817340 BUSINESS ADDRESS: STREET 1: 5655 SPALDING DRIVE STREET 2: 5655 SPALDING DRIVE CITY: NORCROSS STATE: GA ZIP: 30092 BUSINESS PHONE: 4042965595 MAIL ADDRESS: STREET 1: 5655 SPALDING DRIVE STREET 2: 5655 SPALDING DRIVE CITY: NORCROSS STATE: GA ZIP: 30092 FORMER COMPANY: FORMER CONFORMED NAME: SEROLOGICALS HOLDINGS INC DATE OF NAME CHANGE: 19950418 FORMER COMPANY: FORMER CONFORMED NAME: SEROLOGICALS ACQUISITION INC DATE OF NAME CHANGE: 19950418 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD CENTRAL INDEX KEY: 0000919165 IRS NUMBER: 521745745 STATE OF INCORPORATION: MD FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G BUSINESS ADDRESS: STREET 1: 1829 REISTERSTOWN RD STREET 2: SUITE 220 CITY: BALTIMORE STATE: MD ZIP: 21208 BUSINESS PHONE: 4106020195 MAIL ADDRESS: STREET 1: 1829 REISTERSTOWN ROAD STREET 2: SUITE 220 CITY: BALTIMORE STATE: MD ZIP: 21208 SC 13G 1 efc6-1454_5873441sc13g.txt UNITED STATES SECURITIES EXCHANGE COMMISSION Washington, D.C. 20549 - ------------------------------------------------------------------------------ SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. ) SEROLOGICALS CORPORATION ------------------------ (Name of Issuer) Common Stock, $0.01 par value per share ----------------------------------------- (Title of Class of Securities) 817523103 ---------------------------- (CUSIP Number) April 28, 2006 ---------------------------- (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [ ] Rule 13d-1(b) [ X ] Rule 13d-1(c) [ ] Rule 13d-1(d) * The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). Continued on following pages Page 1 of 10 Pages Exhibit Index: Page 9 SCHEDULE 13G CUSIP No.: 817523103 Page 2 of 10 Pages ................................................................................. 1. Names of Reporting Persons. I.R.S. Identification Nos. of above persons (entities only). CHESAPEAKE PARTNERS MANAGEMENT CO., INC. ................................................................................. 2. Check the Appropriate Box if a Member of a Group (a) [ ] (b) [ ] ................................................................................. 3. SEC Use Only ................................................................................. 4. Citizenship or Place of Organization Maryland ................................................................................. Number of 5. Sole Voting Power 0 Shares ............................................................ Beneficially 6. Shared Voting Power 1,866,600 Owned by Each ............................................................ Reporting 7. Sole Dispositive Power 0 Person With ............................................................ 8. Shared Dispositive Power 1,866,600 ................................................................................. 9. Aggregate Amount Beneficially Owned by Each Reporting Person 1,866,600 ................................................................................. 10. Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) [ ] ................................................................................. 11. Percent of Class Represented by Amount in Row (9) 5.5% ................................................................................. 12. Type of Reporting Person: CO SCHEDULE 13G CUSIP No.: 817523103 Page 3 of 10 Pages ................................................................................. 1. Names of Reporting Persons. I.R.S. Identification Nos. of above persons (entities only). MARK D. LERNER ................................................................................. 2. Check the Appropriate Box if a Member of a Group (a) [ ] (b) [ ] ................................................................................. 3. SEC Use Only ................................................................................. 4. Citizenship or Place of Organization United States of America ................................................................................. Number of 5. Sole Voting Power 0 Shares ............................................................ Beneficially 6. Shared Voting Power 1,866,600 Owned by Each ............................................................ Reporting 7. Sole Dispositive Power 0 Person With ............................................................ 8. Shared Dispositive Power 1,866,600 ................................................................................. 9. Aggregate Amount Beneficially Owned by Each Reporting Person 1,866,600 ................................................................................. 10. Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) [ ] ................................................................................. 11. Percent of Class Represented by Amount in Row (9) 5.5% ................................................................................. 12. Type of Reporting Person: HC; IA SCHEDULE 13G CUSIP No.: 817523103 Page 4 of 10 Pages ................................................................................. 1. Names of Reporting Persons. I.R.S. Identification Nos. of above persons (entities only). TRACI LERNER ................................................................................. 2. Check the Appropriate Box if a Member of a Group (a) [ ] (b) [ ] ................................................................................. 3. SEC Use Only ................................................................................. 4. Citizenship or Place of Organization United States of America ................................................................................. Number of 5. Sole Voting Power 0 Shares ............................................................ Beneficially 6. Shared Voting Power 1,866,600 Owned by Each ............................................................ Reporting 7. Sole Dispositive Power 0 Person With ............................................................ 8. Shared Dispositive Power 1,866,600 ................................................................................. 9. Aggregate Amount Beneficially Owned by Each Reporting Person 1,866,600 ................................................................................. 10. Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) [ ] ................................................................................. 11. Percent of Class Represented by Amount in Row (9) 5.5% ................................................................................. 12. Type of Reporting Person: HC; IA Page 5 of 10 Pages Item 1(a). Name of Issuer: Serologicals Corporation (the "Issuer"). Item 1(b). Address of Issuer's Principal Executive Offices: 5655 Spalding Drive, Norcross, GA 30092. Item 2(a). Name of Person Filing This Statement is filed on behalf of each of the following persons (collectively, the "Reporting Persons"): i) Chesapeake Partners Management Co., Inc. ("CPMC"); ii) Mark D. Lerner ("Mr. Lerner"); and iii) Traci Lerner ("Ms. Lerner"). This Statement relates to Shares (as defined herein) held for the accounts of each of Chesapeake Partners Limited Partnership, a Maryland limited partnership ("CPLP"); and Chesapeake Partners International Ltd., a Cayman Islands exempted company ("CPINTL"). CPMC serves as investment manager to each of CPLP and CPINTL. CPMC also serves as the General Partner of CPLP. Mr. Lerner and Ms. Lerner are officers of CPMC. In such capacities, each of CPMC, Mr. Lerner and Ms. Lerner may be deemed to have voting and investment power over the Shares held for each of CPLP and CPINTL. Item 2(b). Address of Principal Business Office or, if 0, Residence The address of the principal business office of each of CPMC, Mr. Lerner and Ms. Lerner is 1829 Reisterstown Road, Suite 420, Baltimore, Maryland 21208. Item 2(c). Citizenship i) CPMC is a Maryland corporation; ii) Mr. Lerner is a citizen of the United States of America; and iii) Ms. Lerner is a citizen of the United States of America. Item 2(d). Title of Class of Securities: Common Stock, $0.01 par value per share (the "Shares"). Item 2(e). CUSIP Number: 817523103 Item 3. If This Statement is Filed Pursuant to ss.ss.240.13d-1(b) or 40.13d-2(b) or (c), Check Whether the Person Filing is a: This Item 3 is not applicable. Page 6 of 10 Pages Item 4. Ownership: Item 4(a). Amount Beneficially Owned: As of May 5, 2006, each of CPMC, Mr. Lerner and Ms. Lerner may be deemed to be the beneficial owner of 1,866,600 Shares. This amount consists of (A) 955,300 Shares held for the account of CPLP, and (B) 911,300 Shares held for the account of CPINTL. Item 4(b). Percent of Class: The number of Shares of which CPMC may be deemed to be the beneficial owner constitutes approximately 5.5% of the total number of Shares outstanding. Item 4(c). Number of Shares of which such person has: CPMC, Mr. Lerner and Ms. Lerner: - -------------------------------- (i) Sole power to vote or direct the vote: 0 (ii) Shared power to vote or direct the vote: 1,866,600 (iii) Sole power to dispose or direct the disposition of: 0 (iv) Shared power to dispose or direct the disposition of: 1,866,600 Item 5. Ownership of Five Percent or Less of a Class: This Item 5 is not applicable. Item 6. Ownership of More than Five Percent on Behalf of Another Person: This Item 6 is not applicable. Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company: See disclosure in Item 2 hereof. Item 8. Identification and Classification of Members of the Group: This Item 8 is not applicable. Item 9. Notice of Dissolution of Group: This Item 9 is not applicable. Page 7 of 10 Pages Item 10. Certification: By signing below each of the Reporting Persons certifies that, to the best of their knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect. Page 8 of 10 Pages SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Date: May 8, 2006 CHESAPEAKE PARTNERS MANAGEMENT CO., INC. By: /s/ Mark D. Lerner ------------------ Name: Mark D. Lerner Title: Vice President Date: May 8, 2006 MARK D. LERNER /s/ Mark D. Lerner ---------------------- Date: May 8, 2006 TRACI LERNER /s/ Traci Lerner ---------------------- Page 9 of 10 Pages EXHIBIT INDEX Ex. Page No. - --- -------- A. Joint Filing Agreement, dated May 8, 2006 by and among Chesapeake Partners Management Co., Inc., Mark D. Lerner and Traci Lerner.........10 Page 10 of 10 Pages EXHIBIT A JOINT FILING AGREEMENT The undersigned hereby agree that the statement on Schedule 13G with respect to the Common Stock of Serologicals Corporation dated as of May 8, 2006 is, and any amendments thereto (including amendments on Schedule 13D) signed by each of the undersigned shall be, filed on behalf of each of us pursuant to and in accordance with the provisions of Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended. Date: May 8, 2006 CHESAPEAKE PARTNERS MANAGEMENT CO., INC. By: /s/ Mark D. Lerner ------------------ Name: Mark D. Lerner Title: Vice President Date: May 8, 2006 MARK D. LERNER /s/ Mark D. Lerner ---------------------- Date: May 8, 2006 TRACI LERNER /s/ Traci Lerner ---------------------- -----END PRIVACY-ENHANCED MESSAGE-----